or an angiotensin receptor blocker (ARB), and 96% were on diuretics. We found that despite a high number of ED visits, the COACH group had no ED visits or hospitalizations for heart failure ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

For patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves adherence to quadruple ...

Switching Between Beta Blockers in Heart Failure Patients: Rationale and Practical Considerations William T. Abraham, MD Disclosures CHF. 2003;9 (5) ...

Review Article Published: December 2006 Mechanisms of Disease: apoptosis in heart failure—seeing hope in death Jagat Narula, Nezam Haider, Eloisa Arbustini & Y Chandrashekhar Nature Clinical ...

Congestive heart failure affects around 6 million Americans with almost 700,000 being diagnosed each year. In fact, Black Americans have the highest rate of heart failure than any other race/ethnic ...

Background In heart failure patients treated with b-blockers the ability to predict likelihood of improvement in LVEF using clinical features is limited. Molecular profiling may improve ...

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according to research presented Tuesday at the British Cardiovascular Society ...

Introduction: Cardiac cachexia is a strong predictor of a poor clinical outcome in patients with heart failure (HF), whereas the prognosis of obese HF patients is more favorable compared with lean ...

Beta-blockers reduce mortality in patients with cardiovascular disease, most notably after myocardial infarction, 19 in the presence of congestive heart failure 20 and in the perioperative setting. 21 ...